| Literature DB >> 33476547 |
Anna M Klawonn1, Michael Fritz2, Silvia Castany3, Marco Pignatelli4, Carla Canal5, Fredrik Similä3, Hugo A Tejeda6, Julia Levinsson3, Maarit Jaarola3, Johan Jakobsson7, Juan Hidalgo5, Markus Heilig3, Antonello Bonci8, David Engblom9.
Abstract
Microglia are activated in many neurological diseases and have been suggested to play an important role in the development of affective disorders including major depression. To investigate how microglial signaling regulates mood, we used bidirectional chemogenetic manipulations of microglial activity in mice. Activation of microglia in the dorsal striatum induced local cytokine expression and a negative affective state characterized by anhedonia and aversion, whereas inactivation of microglia blocked aversion induced by systemic inflammation. Interleukin-6 signaling and cyclooxygenase-1 mediated prostaglandin synthesis in the microglia were critical for the inflammation-induced aversion. Correspondingly, microglial activation led to a prostaglandin-dependent reduction of the excitability of striatal neurons. These findings demonstrate a mechanism by which microglial activation causes negative affect through prostaglandin-dependent modulation of striatal neurons and indicate that interference with this mechanism could milden the depressive symptoms in somatic and psychiatric diseases involving microglial activation.Entities:
Keywords: DREADDs; Microglia; anhedonia; aversion; depression; interleukin-6; neuroinflammation; prostaglandin; striatum
Year: 2021 PMID: 33476547 DOI: 10.1016/j.immuni.2020.12.016
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745